Full-Service CRO Eurotrials Opens New Office In Mexico
LISBON, PORTUGAL, FEBRUARY 22 2016 – Eurotrials, a clinical research organization (CRO) specialized in Europe and Latin America, is pleased to announce the opening of its new office in Mexico City, Mexico. The new office strengthens the company’s presence in Latin America and further boosts its growth and expansion, providing full operational coverage in this key emergent region.
Hector De Lille, MD, Project Manager, will head the new office. Hector has over 12 years of experience in the clinical research area, and is a specialist in Clinical Studies Management in Latin America. “This investment demonstrates Eurotrials’ confidence in the clinical research field in Mexico, one of the most important markets for clinical research today, where several strategic decisions are being taken towards positive development. This will consolidate Eurotrials’ position as a key player in Latin America” said Hector.
Maria João Queiroz, Global CEO at Eurotrials, explains the latest addition in Eurotrials family: ”Eurotrials continues to grow successfully and sustainably as a result of our unique commitment to deliver our clients’ needs on time, on budget and to the highest quality. The office will support the growth of the company’s global business, which helps pharmaceutical, biotechnology and medical device companies bring new therapies and treatments to the market.”
Located in Mexico City centre, the new office is one of its main six sites – including Brazil, Argentina, Chile, Portugal and Spain - dedicated to Eurotrials full-service CRO operations, reinforcing its position and capabilities in all LATAM region. The Mexico-based office specializes in strategic consulting, clinical studies conduct, project management and outcome research. The team helps pharmaceutical and biotechnology partners develop strategic plans for the entire drug development process.
About Eurotrials
Eurotrials is a full-service CRO focused in Europe and Latin America with strong local expertise. The company has been validated by international biopharmaceutical companies, has several master agreements and is ISO- 9001 certified. With more than 20 years of experience, Eurotrials has offices in Mexico, Brazil, Argentina, Chile, Portugal and Spain, covering over 15 countries in both regions. Eurotrials provides an extensive array of services from early- to late-stage research as well as product support in accordance with global and specific regional requirements.
You can visit Eurotrials at the website http://www.eurotrials.com; Twitter: @Eurotrials
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
